US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 2.340
  • -0.060-2.50%
Close Mar 11 16:00 ET
  • 2.340
  • 0.0000.00%
Post 16:05 ET
32.10MMarket Cap-2.03P/E (TTM)

Grace Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-117.49%-4.12M
-100.57%-4.24M
42.36%-3.6M
22.50%-12.33M
37.22%-2.09M
49.17%-1.89M
38.56%-2.11M
-15.00%-6.24M
7.67%-15.91M
-5.76%-3.33M
Net income from continuing operations
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
Operating gains losses
1,034.92%1.18M
---361K
---1.4M
7,864.71%2.71M
1,334.72%1.03M
-647.83%-126K
----
----
100.61%34K
129.88%72K
Depreciation and amortization
100.00%2K
0.00%2K
-85.71%1K
-91.13%11K
-87.50%1K
-90.00%1K
103.28%2K
-95.81%7K
--124K
--8K
Deferred tax
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
24.09%-208K
-187.74%-446K
-19.42%-289K
-1,372.53%-9.54M
-1,268.98%-8.87M
Other non cash items
----
----
--1K
----
----
----
----
----
----
----
Change In working capital
-237.35%-695K
143.75%203K
144.42%900K
-807.18%-1.28M
99.43%704K
1,545.71%506K
-140.92%-464K
-59.40%-2.03M
106.50%181K
-65.79%353K
-Change in receivables
193.44%114K
---19K
1,031.43%326K
126.49%80K
797.06%237K
-234.07%-122K
--0
91.94%-35K
-1,577.78%-302K
89.03%-34K
-Change in prepaid assets
-145.49%-106K
74.70%145K
35.92%-339K
337.50%315K
16.30%528K
-27.64%233K
-38.52%83K
36.95%-529K
118.95%72K
-59.72%454K
-Change in payables and accrued expense
-277.97%-703K
114.34%77K
163.01%913K
-501.95%-1.65M
8.96%-61K
188.17%395K
-158.12%-537K
-72,550.00%-1.45M
117.21%411K
-131.16%-67K
-Change in other current assets
--0
--0
--0
---23K
--0
--0
---10K
---13K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.50%-12.33M
37.22%-2.09M
49.17%-1.89M
38.56%-2.11M
-15.00%-6.24M
7.67%-15.91M
-5.76%-3.33M
Investing cash flow
Cash flow from continuing investing activities
100.23%15K
0
-15K
-99.21%104K
31.17%6.55M
-31.05%-6.55M
214.58%110K
0
473.45%13.15M
45,281.82%4.99M
Net PPE purchase and sale
--0
----
----
623.53%89K
-162.50%-21K
--0
----
----
---17K
---8K
Net investment purchase and sale
100.23%15K
--0
---15K
-99.89%15K
31.38%6.57M
-31.05%-6.55M
--0
--0
473.94%13.17M
45,354.55%5M
Cash from discontinued investing activities
Investing cash flow
100.23%15K
--0
---15K
-99.21%104K
31.17%6.55M
-31.05%-6.55M
214.58%110K
--0
473.45%13.15M
45,281.82%4.99M
Financing cash flow
Cash flow from continuing financing activities
0
2,320.72%7.36M
0
0
304K
0
Net common stock issuance
--0
----
----
2,313.82%7.34M
--0
--0
----
----
--304K
--0
Proceeds from stock option exercised by employees
--0
----
----
--21K
--0
--0
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
----
----
2,320.72%7.36M
--0
--0
----
----
--304K
--0
Net cash flow
Beginning cash position
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-8.12%27.88M
-29.33%18.55M
-22.72%26.99M
-43.63%21.63M
-8.12%27.88M
-40.44%30.34M
-20.51%26.24M
Current changes in cash
51.46%-4.1M
-179.14%-4.24M
42.13%-3.61M
-98.29%-4.87M
167.71%4.46M
3.18%-8.45M
256.33%5.36M
-177.74%-6.24M
88.17%-2.46M
153.16%1.67M
Effect of exchange rate changes
----
----
--0
--0
----
----
----
-118.18%-2K
-105.23%-8K
-106.96%-32K
End cash Position
-40.39%11.06M
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-17.47%23.01M
-29.33%18.55M
-22.72%26.99M
-43.63%21.63M
-8.12%27.88M
-8.12%27.88M
Free cash flow
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.44%-12.36M
36.71%-2.11M
49.17%-1.89M
38.59%-2.11M
-14.85%-6.24M
7.57%-15.93M
-6.01%-3.33M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -117.49%-4.12M-100.57%-4.24M42.36%-3.6M22.50%-12.33M37.22%-2.09M49.17%-1.89M38.56%-2.11M-15.00%-6.24M7.67%-15.91M-5.76%-3.33M
Net income from continuing operations -73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M
Operating gains losses 1,034.92%1.18M---361K---1.4M7,864.71%2.71M1,334.72%1.03M-647.83%-126K--------100.61%34K129.88%72K
Depreciation and amortization 100.00%2K0.00%2K-85.71%1K-91.13%11K-87.50%1K-90.00%1K103.28%2K-95.81%7K--124K--8K
Deferred tax -190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K24.09%-208K-187.74%-446K-19.42%-289K-1,372.53%-9.54M-1,268.98%-8.87M
Other non cash items ----------1K----------------------------
Change In working capital -237.35%-695K143.75%203K144.42%900K-807.18%-1.28M99.43%704K1,545.71%506K-140.92%-464K-59.40%-2.03M106.50%181K-65.79%353K
-Change in receivables 193.44%114K---19K1,031.43%326K126.49%80K797.06%237K-234.07%-122K--091.94%-35K-1,577.78%-302K89.03%-34K
-Change in prepaid assets -145.49%-106K74.70%145K35.92%-339K337.50%315K16.30%528K-27.64%233K-38.52%83K36.95%-529K118.95%72K-59.72%454K
-Change in payables and accrued expense -277.97%-703K114.34%77K163.01%913K-501.95%-1.65M8.96%-61K188.17%395K-158.12%-537K-72,550.00%-1.45M117.21%411K-131.16%-67K
-Change in other current assets --0--0--0---23K--0--0---10K---13K--0--0
Cash from discontinued investing activities
Operating cash flow -117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.50%-12.33M37.22%-2.09M49.17%-1.89M38.56%-2.11M-15.00%-6.24M7.67%-15.91M-5.76%-3.33M
Investing cash flow
Cash flow from continuing investing activities 100.23%15K0-15K-99.21%104K31.17%6.55M-31.05%-6.55M214.58%110K0473.45%13.15M45,281.82%4.99M
Net PPE purchase and sale --0--------623.53%89K-162.50%-21K--0-----------17K---8K
Net investment purchase and sale 100.23%15K--0---15K-99.89%15K31.38%6.57M-31.05%-6.55M--0--0473.94%13.17M45,354.55%5M
Cash from discontinued investing activities
Investing cash flow 100.23%15K--0---15K-99.21%104K31.17%6.55M-31.05%-6.55M214.58%110K--0473.45%13.15M45,281.82%4.99M
Financing cash flow
Cash flow from continuing financing activities 02,320.72%7.36M00304K0
Net common stock issuance --0--------2,313.82%7.34M--0--0----------304K--0
Proceeds from stock option exercised by employees --0----------21K--0--0----------0--0
Cash from discontinued financing activities
Financing cash flow --0--------2,320.72%7.36M--0--0----------304K--0
Net cash flow
Beginning cash position -43.85%15.16M-10.35%19.39M-17.47%23.01M-8.12%27.88M-29.33%18.55M-22.72%26.99M-43.63%21.63M-8.12%27.88M-40.44%30.34M-20.51%26.24M
Current changes in cash 51.46%-4.1M-179.14%-4.24M42.13%-3.61M-98.29%-4.87M167.71%4.46M3.18%-8.45M256.33%5.36M-177.74%-6.24M88.17%-2.46M153.16%1.67M
Effect of exchange rate changes ----------0--0-------------118.18%-2K-105.23%-8K-106.96%-32K
End cash Position -40.39%11.06M-43.85%15.16M-10.35%19.39M-17.47%23.01M-17.47%23.01M-29.33%18.55M-22.72%26.99M-43.63%21.63M-8.12%27.88M-8.12%27.88M
Free cash flow -117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.44%-12.36M36.71%-2.11M49.17%-1.89M38.59%-2.11M-14.85%-6.24M7.57%-15.93M-6.01%-3.33M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More